Edition:
United States

Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

114.34USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$114.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,070,962
52-wk High
$119.80
52-wk Low
$73.70

Chart for

About

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.... (more)

Overall

Beta: 0.35
Market Cap(Mil.): $95,874.12
Shares Outstanding(Mil.): 1,100.99
Dividend: 0.52
Yield (%): 2.39

Financials

  LLY.N Industry Sector
P/E (TTM): 37.74 31.13 34.39
EPS (TTM): 2.31 -- --
ROI: 8.49 15.55 14.96
ROE: 17.03 16.92 16.52

Lilly partners with AC Immune for Alzheimer's treatment

U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.

Dec 12 2018

Lilly partners with AC Immune for Alzheimer's treatment

Dec 12 Eli Lilly & Co and AC Immune SA have agreed to jointly develop a potential treatment for Alzheimer's disease.

Dec 12 2018

UPDATE 3-Bayer to sell businesses, cut jobs after Monsanto deal

* Around 12,000 jobs to go (Adds asset values, potential buyers of animal health unit)

Nov 29 2018

UPDATE 2-Bayer looks at options for consumer brands, animal health -sources

* Bayer seeks to cut debt in wake of Monsanto takeover (Adds detail, context)

Nov 26 2018

Merck says to retain animal health business as part of company

Oct 25 Merck & Co Inc on Thursday indicated that it would keep its animal health business as part of the company, in response to questions about its plans for the unit.

Oct 25 2018

Eli Lilly can't shake $20 million Cialis patent verdict on appeal

A federal appeals court on Wednesday rejected Eli Lilly and Co’s effort to set aside a $20 million jury verdict in a patent lawsuit over the company's erectile dysfunction drug Cialis.

Oct 10 2018

Wall Street stumbles as bond yield climb continues

NEW YORK Wall Street stocks stumbled on Thursday as U.S. Treasury yields continued their ascent to multi-year highs on the latest round of strong economic data, building concerns for an acceleration of inflation. | Video

Oct 04 2018

Boost for 'made in China' medicine as Chi-Med wins key approval

LONDON Hutchison China MediTech has won Chinese approval for a closely watched new cancer drug in a significant boost for "made in China" medicine.

Sep 05 2018

Insurance tactic drags down U.S. drug prices in second quarter: analyst

NEW YORK U.S. drug prices fell again in the second quarter, likely due to a new tactic insurers are using to limit financial assistance drugmakers provide directly to consumers, according to research firm Sector and Sovereign Research (SSR).

Sep 04 2018

UPDATE 1-Insurance tactic drags down U.S. drug prices in 2nd qtr -analyst

NEW YORK, Sept 4 U.S. drug prices fell again in the second quarter, likely due to a new tactic insurers are using to limit financial assistance drugmakers provide directly to consumers, according to research firm Sector and Sovereign Research (SSR).

Sep 04 2018

Earnings vs. Estimates